http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-065837-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8717d5adbd69b54b22a23d835ab2c29 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 |
| filingDate | 2008-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ba0960b1b694696220842e2f6e0066a |
| publicationDate | 2009-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-065837-A1 |
| titleOfInvention | COMPOSITION FOR THE TREATMENT OF METABOLIC SYNDROME |
| abstract | A composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5'-monophosphate activated protein kinase activator (AMPK); a second agent that possesses anti-inflammatory activity; and a third agent that possesses a serotonin activity. Claim 2: The composition of claim 1, wherein the first agent is metformin, fenformin, buformin, ephedrine, thyroxine, salicylanilide, salicylic acid. Claim 4: The composition of claim 1, wherein the second agent is a non-steroidal anti-inflammatory compound. Claim 5: The composition of claim 1, wherein the second esapirin agent, diclofenac, ibuprofen, indomethacin, acetaminophen, nimesulide, or a COX-2 inhibitor. Claim 7: The composition of claim 1, wherein the third agent is serotonin or a serotonin reuptake inhibitor. Claim 8: The composition of claim 7, wherein the third agent is serotonin sulfate, a serotonin-creatinine sulfate complex, or serotonin hydrochloride. |
| priorityDate | 2007-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.